Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: SLAB51
Total 1 results
University Hospital, Geneva
Not yet recruiting
Dynamic Response to Probiotics in Context of Alzheimer Disease: a Proof-of-concept Study (HISTEPPA)
Alzheimer Disease
Sponsors and Collaborators
Hospital Durand, Argentina
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Apollo Neuroscience, Inc.
RMIT University, Melbourne, Australia
Aptis Medical
ASST Cremona, Cremona
Korean Society of Spine Surgery
Everett Meyer
Nacuity Pharmaceuticals, Inc.
Hospital ASEPEYO Sant Cugat
Eurofins Genoma
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
iCAD
Neurophth Therapeutics Inc
GFI
Agency for Science, Technology and Research
Mª Victoria Maestre Sanchez
Kupfer, David J., M.D.
Alma Lasers Inc.
View Full List
Medical Conditions
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Major Liver Surgery
Splenic Trauma
Dienogest
Immune-Mediated Inflammatory Disease
Fever
Treatment Decisions
Luteal Phase Support
Corneal Cross-Linking
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Disorder of Fluid Balance
Rheumatoid Arthritis(RA)
RISS Stage III Plasma Cell Myeloma
T-LGL Leukemia
Metachronous Adenoma
Gastric Cancer Stage IIIB-IIIC
Scleredema
The Strength Properties of the Aorta in Vitro
Chronic Constipation Symptoms
Recurrent Clear Cell Sarcoma of Soft Tissue
View Full List
Drug Interventions
Intravenous Formulation of PD-0332991
OnabotulinumtoxinA
Capecitabine and IMRT (if randomized to this arm)
Midazolam
Camptosar
Olopatadine
MLN2480
Standard of care (SOC) for COVID-19
THC
Intravenous deferiprone
TPN-101
Anticholinergic
GLPG1837 multiple ascending doses
Oxycodone/acetaminophen 5/325 mg
Fospropofol disodium, propofol
Desvenlafaxine
RDX227675
PD-1/PD-L1 inhibitor
Capecitabine/cisplatin
Letrozole
View Full List
CROs by country
Contract Research Organizations in Congo
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Egypt
Contract Research Organizations in Ethiopia
Contract Research Organizations in Germany
Contract Research Organizations in Guinea
Contract Research Organizations in Israel
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Liberia
Contract Research Organizations in Montenegro
Contract Research Organizations in Nigeria
Contract Research Organizations in Paraguay
Contract Research Organizations in Senegal
CRO list by country
CROs in Portugal
SGS
W4Research
Pivotal
PPD
Blueclinical
IQVIA
Alpha Bioresearch
Fortrea
VectorB2B
All CROs in Portugal
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe